Presentations: South Africa’s HIV, TB investment case


In 2011, UNAIDS released its investment framework, aimed at helping countries prioritise funding options amid a downturn in funding.
Countries like Zimbabwe and Malawi have gone on to formulate national investment cases broadly guided by this document.
On 30 July 2014, the South African National AIDS Council (SANAC) convened a consultation to review the country’s investment framework. Below are three experts’ presentations.
Eva Kiwango, UNAIDS senior strategic information advisor
Although Kiwango cites the gains made by South Africa, she notes that challenges remain including early sexual debut, high loss to follow up among antiretroviral patients and structural drivers fueling new infections among women. She adds that the country’s investment framework could have important impacts for the formulation of domestic budgets including the medium term expenditure framework, HIV conditional grant and provincial equitable share formulation.
Download Kiwango’s presentation: Kiwango Investment Case Background_30 July 2014
Dr Gesine Meyer-Rath, Health Economics and Epidemiology Research Office
Previously, Meyer-Rath helped produce one of the country’s first detailed costings supporting the government’s move to early HIV treatment at a higher CD4 count of 350. In this presentation, she discusses the analytical framework for an investment case and possible data sources.
Download Meyer-Rath’s presentation: Meyer-Rath Investment Case 30 July
The final presentation outlines possible factors that may enable a better HIV and tuberculosis response in South Africa as well as technical efficiencies to be gained and possible challenges by sector.
Download the final presentation: Final SANAC Investment Framework Feedback 31 July
Author
Republish this article

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
-
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
-
You must include all of the links from our story, including our newsletter sign up link.
-
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
-
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
-
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
-
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Presentations: South Africa’s HIV, TB investment case
by healthe, Health-e News
August 21, 2014